MTI Ltd. (JP:9438)
:9438
Want to see JP:9438 full AI Analyst Report?
Top Page
MTI Ltd.
(9438)
Select Model
Select Model
Rating:71Outperform
Price Target:
¥652.00
▼(-9.57% Downside)
Action:Reiterated
Date:02/14/26
The score is driven primarily by strong financial performance (high margins, low leverage, and improved cash flow), partially offset by weak technicals (trading below major moving averages with negative MACD and a low RSI). Valuation is supportive with a reasonable P/E and a mid-level dividend yield.
Positive Factors
High Profitability
Sustained high gross margin (74.3%) and healthy net margin (11.4%) reflect a scalable digital-content model with low incremental costs. Margins provide durable cash buffer to fund R&D, marketing and strategic initiatives, supporting profitability through medium-term cycles.
Negative Factors
Slowing Revenue Growth
Revenue growth decelerated to only +1.61% in the latest year, which may signal market saturation in core digital services or competitive pressure. Slower top-line expansion constrains future operating leverage and limits the pace at which margins and cash generation can scale.
Read all positive and negative factors
Positive Factors
Negative Factors
High Profitability
Sustained high gross margin (74.3%) and healthy net margin (11.4%) reflect a scalable digital-content model with low incremental costs. Margins provide durable cash buffer to fund R&D, marketing and strategic initiatives, supporting profitability through medium-term cycles.
Read all positive factors
MTI Ltd. (9438) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥31.50B
Dividend Yield2.58%
Average Volume (3M)62.04K
Price to Earnings (P/E)9.3
Beta (1Y)0.40
Revenue Growth5.70%
EPS Growth35.98%
CountryJP
Employees1,184
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)61.65
Shares Outstanding60,435,200
10 Day Avg. Volume33,460
30 Day Avg. Volume62,043
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)2.31
Price to Sales (P/S)1.42
P/FCF Ratio7.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)39.6
Revenue Forecast (FY)¥30.40B
MTI Ltd. Business Overview & Revenue Model
Company Description
MTI Ltd. (9438) is a publicly traded company primarily engaged in the development and provision of innovative technology solutions, focusing on sectors such as telecommunications, information technology, and consumer electronics. The company speci...
How the Company Makes Money
MTI Ltd. generates revenue through the subscription-based model for its digital content and services. Users subscribe to the company's platforms for access to premium features, such as health management tools, music streaming, and e-book libraries...
MTI Ltd. Financial Statement Overview
Summary
Income Statement
82
Very Positive
Balance Sheet
78
Positive
Cash Flow
75
Positive
| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 29.91B | 27.67B | 26.80B | 26.48B | 25.74B |
| Gross Profit | 22.22B | 20.40B | 18.37B | 18.69B | 18.74B |
| EBITDA | 6.02B | 5.17B | 2.91B | 1.44B | 2.45B |
| Net Income | 3.40B | 2.36B | 753.22M | -930.48M | -1.16B |
Balance Sheet | |||||
| Total Assets | 33.35B | 29.70B | 29.17B | 29.28B | 31.91B |
| Cash, Cash Equivalents and Short-Term Investments | 17.82B | 14.83B | 13.72B | 12.10B | 15.54B |
| Total Debt | 1.69B | 2.43B | 3.18B | 3.93B | 2.88B |
| Total Liabilities | 10.90B | 10.55B | 11.58B | 11.40B | 10.67B |
| Stockholders Equity | 18.41B | 15.47B | 14.01B | 14.18B | 17.59B |
Cash Flow | |||||
| Free Cash Flow | 5.58B | 2.74B | 3.60B | -3.59B | 1.74B |
| Operating Cash Flow | 5.66B | 4.13B | 4.76B | -1.39B | 3.52B |
| Investing Cash Flow | -1.02B | -1.37B | -1.35B | -2.46B | -2.00B |
| Financing Cash Flow | -1.63B | -1.64B | -1.78B | 343.54M | 649.18M |
MTI Ltd. Technical Analysis
Neutral
721.00
Price Trends
602.65
Negative
646.63
Negative
710.28
Negative
Market Momentum
-7.82
Negative
52.39
Neutral
67.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9438, the sentiment is Neutral. The current price of 721 is above the 20-day moving average (MA) of 580.05, above the 50-day MA of 602.65, and above the 200-day MA of 710.28, indicating a neutral trend. The MACD of -7.82 indicates Negative momentum. The RSI at 52.39 is Neutral, neither overbought nor oversold. The STOCH value of 67.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:9438.
MTI Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥31.50B | 9.33 | ― | 2.58% | 5.70% | 35.98% | |
68 Neutral | ¥1.05T | 21.71 | 12.15% | 1.01% | 23.33% | 21.65% | |
60 Neutral | ¥175.05B | 26.68 | ― | 0.43% | 20.95% | 13.39% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥67.21B | 67.53 | 5.76% | ― | 23.30% | -56.05% | |
43 Neutral | ¥2.48B | -4.57 | ― | ― | 18.86% | 38.80% |
* Healthcare Sector Average
JP:9438
MTI Ltd.
590.00
-245.34
-29.37%
JP:2413
M3
1,590.00
-470.52
-22.84%
JP:4480
Medley
2,199.00
-801.00
-26.70%
JP:4438
Welby Inc.
288.00
-67.00
-18.87%
JP:4483
JMDC Inc.
2,759.00
-917.12
-24.95%
MTI Ltd. Corporate Events
MTI Sets FY2026 Strategy Around Healthcare and School DX Growth
May 13, 2026
MTI Ltd. released materials for its Q2 FY2026 financial results briefing, outlining consolidated profit and loss, SGA trends, balance sheet data, segment performance, and a revised full-year earnings forecast. Management also detailed basic polici...
MTI Posts Higher H1 Earnings but Signals Full-Year Profit Decline
May 12, 2026
MTI Ltd. reported consolidated net sales of ¥15.67 billion for the first half of the fiscal year ending September 30, 2026, up 5.2% year on year, with operating income rising slightly to ¥1.68 billion and ordinary income climbing nearly ...
MTI Maintains 10 Yen Interim Dividend Despite Strong First-Half Results
May 12, 2026
MTI Ltd. has declared an interim dividend of 10 yen per share, with March 31, 2026 as the record date, maintaining the payout level in line with its stable dividend policy. The total cash distribution will amount to 557 million yen, up from 499 mi...
MTI Raises Earnings Forecasts on Healthcare and DX Growth
May 8, 2026
MTI Ltd. has sharply upgraded its earnings outlook for the first half of the fiscal year ending September 30, 2026, citing stronger-than-expected revenue growth in its healthcare and corporate DX support businesses. The company now forecasts highe...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.